About the OSU College of Pharmacy: The College of Pharmacy prepares students of today to be the pharmacy practitioners and pharmaceutical sciences researchers of tomorrow by contributing to improved health, advancing patient care and the discovery and understanding of medicines.

Lipid-based nanoparticles enable improved therapy for cystic fibrosis patients

PORTLAND, Ore. – Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients

Oregon State University names interim dean of College of Pharmacy

Oregon State University Provost and Executive Vice President Ed Feser has announced that Mark Leid, a professor and associate dean for research in the College of Pharmacy, will serve as interim dean of the college effective July 1.

Researchers take key step toward growing human organs in laboratory

Researchers have learned that precursor cells for skeletal muscles actually also give rise to neurons, blood vessels, blood cells and immune cells, pushing science one step closer to generating body parts in a laboratory.

Oilseed crop’s waste product yields compounds that protect skin from the sun

Meadowfoam, a native Pacific Northwest plant cultivated as an oilseed crop, has emerged as a potential new source of protection against the sun’s harmful effects on the skin.

Cell-penetrating “nanodrills” show promise for intracellular drug delivery

Researchers have created new nanomaterials able to cross cell membranes, establishing a novel platform for the intracellular delivery of molecular drugs and other cargo.

Researchers take important step toward gonorrhea vaccine

Researchers are paving the way toward a new therapeutic approach for gonorrhea by shedding light on the mechanism behind important proteins on the Neisseria gonorrhoeae bacteria’s outer membrane. 

Gonorrhea researchers identify novel route to vaccine, new antibiotic

Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.

Expensive drug driving up Medicare expenditures without evidence of greater efficacy

Medicare spent more than $1 billion over a five-year period on a high-priced drug that has not been proven more effective for a collection of inflammatory conditions than much less expensive corticosteroids, research by the OSU/OHSU College of Pharmacy shows.